A Swiss-based pharmaceutical manufacturer focused on patented medicines across areas such as oncology, cardiovascular disease, immunology, and neuroscience. The company generates the majority of its revenue from innovative branded drugs sold globally and maintains a large clinical development pipeli...
1 member of Congress has disclosed 1 trade in Novartis AG (NVS), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 0 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2002-04-10 | MICHAEL T. MCCAUL | buy | $1K – $15K |